Tea polyphenols regulate key mediators on inflammatory cardiovascular diseases

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Suzuki, Jun Ichi ^a   Isobe, Mitsuaki ^b   Morishita, Ryuichi ^c   Nagai, Ryozo ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; NITRIC OXIDE; POLYPHENOL DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; FLAVONOID; PHENOL DERIVATIVE; POLYPHENOLS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DRUG POTENCY; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEART VENTRICLE REMODELING; INFLAMMATION; MEDIATOR RELEASE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TEA; ANIMAL; BIOLOGICAL MODEL; DISEASE MODEL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOUSE; RAT;

MURINAE; RATTUS;

ANIMALS; CARDIOVASCULAR DISEASES; CATECHIN; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; NITRIC OXIDE; PHENOLS; RATS; SIGNAL TRANSDUCTION; TEA;

EID: 68949143092     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/494928     Document Type: Review

References (45)

1. Mukamal K. J., Maclure M., Muller J. E., Sherwood J. B., Mittleman M. A., Tea consumption and mortality after acute myocardial infarction Circulation 2002 105 21 2476 2481
2. Arts I. C. W., Hollman P. C. H., Feskens E. J. M., Bueno de Mesquita H. B., Kromhout D., Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study American Journal of Clinical Nutrition 2001 74 2 227 232
3. Kuriyama S., Shimazu T., Ohmori K., Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study Journal of the American Medical Association 2006 296 10 1255 1265
4. Shimazu T., Kuriyama S., Hozawa A., Dietary patterns and cardiovascular disease mortality in Japan: a prospective cohort study International Journal of Epidemiology 2007 36 3 600 609
5. Kuriyama S., The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies Journal of Nutrition 2008 138 8 1548S 1553S
6. Ishikawa T., Suzukawa M., Ito T., Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification American Journal of Clinical Nutrition 1997 66 2 261 266
7. Jankun J., Selman S. H., Swiercz R., Skrzypczak-Jankun E., Why drinking green tea could prevent cancer Nature 1997 387 6633 561
8. Beecher G. R., Warden B. A., Merken H., Analysis of tea polyphenols Proceedings of the Society for Experimental Biology and Medicine 1999 220 4 267 270
9. Yang C. S., Landau J. M., Huang M.-T., Newmark H. L., Inhibition of carcinogenesis by dietary polyphenolic compounds Annual Review of Nutrition 2001 21 381 406
10. Lin Y.-L., Lin J.-K., (-)-epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor- B Molecular Pharmacology 1997 52 3 465 472
11. Benelli R., Vene R., Bisacchi D., Garbisa S., Albini A., Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases Biological Chemistry 2002 383 1 101 105
12. Suzuki J.-I., Ogawa M., Maejima Y., Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats Journal of Molecular and Cellular Cardiology 2007 42 2 432 440
13. Suzuki J.-I., Ogawa M., Futamatsu H., Kosuge H., Sagesaka Y. M., Isobe M., Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis European Journal of Heart Failure 2007 9 2 152 159
14. Suzuki J.-I., Ogawa M., Sagesaka Y. M., Isobe M., Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts Cardiovascular Research 2006 69 1 272 279
15. Suzuki J.-I., Ogawa M., Izawa A., Sagesaka Y. M., Isobe M., Dietary consumption of green tea catechins attenuate hyperlipidaemia-induced atherosclerosis and systemic organ damage in mice Acta Cardiologica 2005 60 3 271 276
16. Taylor D. O., Edwards L. B., Boucek M. M., Trulock E. P., Keck B. M., Hertz M. I., The registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report2004 Journal of Heart and Lung Transplantation 2004 23 7 796 803
17. Pinney S. P., Mancini D., Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention, and treatment Current Opinion in Cardiology 2004 19 2 170 176
18. Suzuki J.-I., Isobe M., Aikawa M., Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts: a study in rat and monkey models Circulation 1996 94 5 1118 1124
19. Hosenpud J. D., Immune mechanisms of cardiac allograft vasculopathy: an update Transplant Immunology 1993 1 4 237 249
20. Suzuki J.-I., Cole S. E., Batirel S., Tumor necrosis factor receptor-1 and -2 double deficiency reduces graft arterial disease in murine cardiac allografts American Journal of Transplantation 2003 3 8 968 976
21. Isobe M., Yagita H., Okumura K., Ihara A., Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1 Science 1992 255 5048 1125 1127
22. Kosuge H., Suzuki J.-I., Gotoh R., Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway Transplantation 2003 75 8 1374 1380
23. Kosuge H., Suzuki J.-I., Kakuta T., Attenuation of graft arterial disease by manipulation of the LIGHT pathway Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 8 1409 1415
24. Koga N., Suzuki J.-I., Kosuge H., Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 11 2057 2062
25. Tripathi S., Bruch D., Gatto L. A., Kittur D. S., Green tea extract prolongs allograft survival as an adjunctive therapy along with low dose cyclosporine A Journal of Surgical Research 2009 154 1 85 90
26. Morishita R., Sugimoto T., Aoki M., In vivo transfection of cis element decoy against nuclear factor- B binding site prevents myocardial infarction Nature Medicine 1997 3 8 894 899
27. Li C., Browder W., Kao R. L., Early activation of transcription factor NF- B during ischemia in perfused rat heart American Journal of Physiology 1999 45 H543 H552
28. Li Q., Verma I. M., NF- B regulation in the immune system Nature Reviews Immunology 2002 2 725 734
29. Chandrasekar B., Freeman G. L., Induction of nuclear factor B and activation protein 1 in postischemic myocardium FEBS Letters 1997 401 1 30 34
30. Onai Y., Suzuki J.-I., Kakuta T., Inhibition of I B phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury Cardiovascular Research 2004 63 1 51 59
31. Haas G. J., Etiology, evaluation, and management of acute myocarditis Cardiology in Review 2001 9 2 88 95
32. Oakley C. M., General cardiology: myocarditis, pericarditis and other pericardial diseases Heart 2000 84 4 449 454
33. Batra A. S., Lewis A. B., Acute myocarditis Current Opinion in Pediatrics 2001 13 3 234 239
34. Zee-Cheng C. S., Tsai C. C., Palmer D. C., Codd J. E., Pennington D. G., Williams G. A., High incidence of myocarditis by endomyocardial biopsy in patients with idiopathic congestive cardiomyopathy Journal of the American College of Cardiology 1984 3 1 63 70
35. Parrillo J. E., Aretz H. T., Palacios I., Fallon J. T., Block P. C., The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis Circulation 1984 69 1 93 101
36. Yokoseki O., Suzuki J.-I., Kitabayashi H., cis Element decoy against nuclear factor- B attenuates development of experimental autoimmune myocarditis in rats Circulation Research 2001 89 10 899 906
37. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., Shibata A., A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction Clinical Immunology and Immunopathology 1990 57 2 250 262
38. Kodama M., Izumi T., Experimental autoimmune myocarditis Acta Bio Medica 1991 39 1 10
39. Kitabayashi H., Isobe M., Watanabe N., Suzuki J.-I., Yazaki Y., Sekiguchi M., FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes Journal of Cardiovascular Pharmacology 2000 35 3 410 416
40. Futamatsu H., Suzuki J.-I., Kosuge H., Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway Cardiovascular Research 2003 59 1 95 104
41. Babu P. V. A., Liu D., Green tea catechins and cardiovascular health: an update Current Medicinal Chemistry 2008 15 18 1840 1850
42. Paquay J. B. G., Haenen G. R. M. M., Stender G., Wiseman S. A., Tijburg L. B. M., Bast A., Protection against nitric oxide toxicity by tea Journal of Agricultural and Food Chemistry 2000 48 11 5768 5772
43. Agnetti G., Bordoni A., Angeloni C., Green tea modulation of inducible nitric oxide synthase in hypoxic/reoxygenated cardiomyocytes Biochimie 2005 87 5 457 460
44. Yamakuchi M., Bao C., Ferlito M., Lowenstein C. J., Epigallocatechin gallate inhibits endothelial exocytosis Biological Chemistry 2008 389 7 935 941
45. Suzuki J.-I., Morishita R., Amano J., Kaneda Y., Isobe M., Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts Gene Therapy 2000 7 21 1847 1852